Results 141 to 150 of about 114,380 (262)

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma. [PDF]

Ann Surg Oncol
Torii K, Iizuka A, Shimizu D, Nakanishi K, Tanaka C, Nakagawa N, Umeda S, Sato Y, Tanaka H, Takami H, Hattori N, Hayashi M, Kanda M.   +12 more
europepmc   +1 more source

Growth hormone supplementation in women who are not poor responders. [PDF]

J Assist Reprod Genet, 2021
Cozzolino M.
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Addition of Clomiphene Citrate to a Low-Dose Gonadotropin-Releasing Hormone (GnRH)-Antagonist Protocol in Poor Responders: A Prospective Cohort Study. [PDF]

Cureus
Triantafyllidou O, Panagodimou E, Chasiakou S, Gkontelos A, Karkalemis K, Simopoulou M, Tzanakaki D, Syggelos N, Kalampokas T, Vakas P, Lazaridis A, Vlahos F, Christopoulos P, Vlahos N.   +13 more
europepmc   +1 more source

Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus. [PDF]

J Immunol Res, 2022
Bononi I, Mazzoni E, Pietrobon S, Iaquinta MR, Caselli A, Torreggiani E, Pugliatti M, Casetta I, Castellazzi M, Granieri E, Martini F, Tognon M.   +11 more
europepmc   +1 more source

The role of bioavailable inhibin B in predicting oocyte yield in expected poor responders: the forgotten marker? [PDF]

J Assist Reprod Genet
Melado L, Kumar A, Kalra B, Kalafat E, Lawrenz B, Fatemi H.   +5 more
europepmc   +1 more source

A Feasible Option before Cycle Cancellation for Poor Responders; STOP-START Protocol. [PDF]

Int J Fertil Steril, 2021
Atabekoğlu CS, Şükür YE, Özmen B, Sönmezer M, Berker B, Aytaç R.   +5 more
europepmc   +1 more source

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee, Shufeng Li, Srijana Davuluri, Jennifer Lee, Lorinda Chung   +4 more
wiley   +1 more source

"Reverse" Dual Stimulation Has Comparable Efficacy, but Higher Efficiency, than Two Conventional Follicular Phase Stimulations in Poor Responders Undergoing In Vitro Fertilization. [PDF]

J Clin Med
Carosso AR, Benedetto C, Evangelisti B, Carosso M, Contangelo G, Canosa S, Gennarelli G, Revelli A.   +7 more
europepmc   +1 more source